Evaluation of p53, Ki-67 and DNA ploidy in both primary rectal carcinomas and locally recurrent tumors

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1225-1229

  Sato, Takahiro ^a   Nishimura, Genichi ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Yonemura, Yutaka ^a   Nonomura, Akitaka ^b   Miwa, Koichi ^a   Miyazaki, Itsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

DNA ploidy; Ki 67; Local recurrence; p53; Rectal cancer

Indexed keywords

CELL DNA; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLOIDY; PRIORITY JOURNAL; RECTUM CARCINOMA; RECURRENCE RISK; RISK ASSESSMENT;

EID: 0031874801     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1225     Document Type: Article

References (22)

1. Willett CG, Tepper JE and Cohen AM, Orlow E and Welch CE: Failure patterns following curative resection of colonie carcinoma. Ann Surg 200: 685-690, 1984.
2. Enker WE, Pilipshen SJ and Heilweil ML, Steams MW, Janov AJ, Hertz RE and Sternberg SS: En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of the rectal cancer. Ann Surg 203: 426-433, 1986.
3. Michelassi F, Vannucci L, Ayala IJ, Chappel R, Goldberg R and Block GE: Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 108: 787-793, 1990.
4. Phillips RKS, Hittinger R, Blesovsky L, Fry JS and Fielding LP: Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg 71: 12-16, 1984.
5. Schiessel R, Wunderlich M and Herbst F: Local recurrence of colorectal cancer: effect of early detection and agressive surgery. Br J Surg 73: 342-344, 1986.
6. Michalovitz D, Halvey O and Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature sensitive mutant of p53. Cell 62: 671-680, 1990.
7. Poller DN, Baxter KJ and Shepherd NA: p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75: 87-93, 1997.
8. Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzman JA, Paulsen JK and Moertel CG: DNA ploidy and cell kinetics measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 68: 879-888 1991.
9. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U and Stein H: Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by monoclonal antibody Ki-67. J Immunol 133: 1710-1717, 1984.
10. Shi S-R, Key ME and Kalra KL: Antigen retrieval in formalinfixed, paraffin embedded tissues: an enhancement method for immunohistochemical staining based upon microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
11. Bacus JW and Grace LJ: Optical microscope system for standardized cell measurements and analyses. Appl Optics 26: 3280-3293, 1987.
12. Bacus JW, Hernicz RS and Bacus JV: Dual wavelength imaging microdensitometry for immunocytochemical assays in microscopy. SPIE 2622: 704-711, 1995.
13. Hedley D, Friedlander M, Taylor I, Rugg C and Musgrove E: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335, 1983.
14. Vindeløv L, Christensen I and Nissen N: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
15. Sato T, Nishimura G, Yonemura Y, Nojima N, Ninomiya I, Fujimura T, Sugiyama K, Miwa K, Miyazaki I, Nonomura A and Yamaguchi A: Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer. Oncology 52: 347-352, 1995.
16. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ and Thomas G: Association of p53 mutations with short survival in colorectal cancer. Gastroenterol 106: 42-48, 1994.
17. Scott NP, Sagar P, Stewart J, Blair GE, Dixon MF and Quirke P: p53 in colorectal cancer: clinicopalhological correlation and prognostic significance. Br J Cancer 63: 317-319, 1991.
18. Armitage NCM, Ballantyne KC, Sheffield JP, Clarke P, Evans DF and Hardcastle JD: A prospective evaluation of the effect tumor cell DNA content on recurrence in colorectal cancer. Cancer 67: 2599-2604, 1991.
19. Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW and Leiber MM: Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 122: 1375-1379, 1987.
20. Kamel OW, Frankin WA, Ringus JC and Meyer JS: Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 134: 107-113, 1989.
21. Sasaki K, Matsumura K, Tsuji T, Shinozaki F and Takahashi M: Relationship between labeling indices of Ki-67 and BrdU in human malignant tumors. Cancer 62: 989-993, 1988.
22. Desai GR, Myerson RJ, Kigashikubo R, Birnbaum E, Fleshman J, Fry R, Kodner I, Kucik N, Lacey D and Ribeiro M: Carcinoma of the rectun: possible cellular predictors of metastatic potential and response to radiation thearapy. Dis Colon Rectum 39: 1090-1096, 1996.